Tonghua Golden-Horse Stock Hits Day Low Amid Price Pressure at CNY 15.57

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. experienced a significant decline today, with the stock dropping by 5.99% to reach an intraday low of CNY 15.57. This performance marks a stark contrast to the China Shanghai Composite, which saw a slight increase of 0.04% on the same day. Over the past week, Tonghua Golden-Horse has faced a 4.35% decrease, and its one-month performance reflects a decline of 3.71%. The company's year-to-date performance is particularly notable, with a drop of 42.34%, while the broader market has only seen a 1.6% decline during the same period. Financial metrics indicate challenges for the company, including a low Return on Capital Employed (ROCE) of 2.62% and a Return on Equity (ROE) of 1.37%. The company has reported negative results for the last three consecutive quarters, with net profit declining by 58.14% and net sales decreasing by 10.62%. Despite being net-debt free, the company has struggled with profitability, reflected in its high Price to Earnings (P/E) ratio of 729.00. Overall, Tonghua Golden-Horse's performance continues to lag behind the market, raising concerns about its financial health and growth prospects.